Cannabis Use and Violence Risk in a Review of More Than 265,000 People
A review of more than 265,000 people found a clear association between cannabis use and higher rates of both committing violence and becoming a victim of violence. The signal was strong enough to merit attention in clinical practice, even though association alone cannot establish that cannabis itself is the direct cause. In a field where the conversation often stays centered on intoxication, dependence, or cognitive effects, violence risk deserves a place in the same clinical frame.
The scale of the analysis matters. Studies that pool data from such a large population can reveal patterns that smaller cohorts miss, especially when the outcome is uncommon or shaped by multiple social and psychiatric factors. Violence is rarely explained by one exposure alone. Cannabis use may cluster with substance use disorders, psychosocial instability, trauma histories, or other variables that already elevate risk, which is precisely why the finding should be interpreted carefully rather than dismissed.
The review linked cannabis use with higher rates of two distinct outcomes: perpetration of violence and victimization. Those are not interchangeable endpoints. Someone who is intoxicated, disinhibited, or living in a high-conflict environment may be more likely to enter situations where aggression escalates, while another person may be drawn into the same environments as a target rather than an initiator. Clinical assessment has to keep both directions in view.
Violence risk in the context of cannabis use may be mediated by several overlapping mechanisms. Acute intoxication can impair judgment, reduce threat appraisal, and alter emotional regulation. In some users, especially those with co-occurring anxiety, paranoia, or psychosis vulnerability, cannabis can amplify suspiciousness or irritability rather than calm it. Those pathways do not prove causation in this review, but they make the association biologically plausible.
A single sentence captures the bedside concern: cannabis use did not appear in this review as a neutral background variable.
For clinicians, the finding argues for more direct screening. A routine history that stops at “Do you use cannabis?” misses the more relevant questions: how often, in what setting, alongside which other substances, and whether use occurs before arguments, driving, or other high-risk situations. The answer can shift counseling from a vague warning to a concrete safety discussion. That matters in emergency departments, primary care, addiction medicine, and mental health clinics alike.
The review’s limitations are built into its design. An association across more than 265,000 people still leaves open the possibility of confounding, reverse causation, and selection bias. People already at higher risk of violence may be more likely to use cannabis, seek other substances, or live under conditions that heighten both exposure and harm. A review can show correlation at scale, but it cannot isolate cannabis as the sole driver without stronger causal designs.
Even so, the clinical implication is not subtle. When cannabis use is present, violence screening should not be reserved for patients who volunteer alarming histories. The combination of intoxication, psychiatric symptoms, social instability, and concurrent substance use can turn an apparently routine visit into an opportunity to identify risk before injury occurs. For patients, the conversation should include safety planning, not moralizing; for clinicians, it should include documentation, follow-up, and referral when needed.
Public health messaging around cannabis has often focused on legality, product potency, or impairment behind the wheel. This review adds another outcome that belongs in the same conversation: interpersonal harm. The evidence does not prove that cannabis causes violence in every user, and it does not justify sweeping assumptions about individual behavior. It does justify a more cautious, more detailed clinical approach when cannabis use enters the chart.
The unanswered issue is not whether cannabis is ever associated with violence — this review says it is. The harder question is which patients are most vulnerable, under what circumstances, and whether that risk can be reduced through screening, treatment of co-occurring disorders, and targeted counseling rather than broad warning alone.